Literature DB >> 23052914

Pattern and characteristics of advanced cancer patients admitted to hospices in Italy.

Sebastiano Mercadante1, Alessandro Valle, Silvana Sabba, Antonio Orlando, Francesca Guolo, Loretta Gulmini, Sara Ori, Rosanna Bellingardo, Alessandra Casuccio.   

Abstract

The aim of this multicenter study was to assess the pattern and the characteristics of advanced cancer patients admitted to hospices. A consecutive sample of patients admitted in a period of 6 months was taken into consideration. Two hundred thirty-six patients admitted to hospices were consecutively assessed. Ninety-six percent of patients were admitted in acute hospital in the previous 3 months, with a mean time spent in hospital of 34.5 days, and 47 % of patients had received chemotherapy the month before hospice admission. Thirty-four percent of patients for whom data were available had significant persistent pain, and 44 % of them presented episodes of breakthrough pain. Sixty-one percent of patients were receiving opioid drugs at admission, and 70 % the day before death, with parenteral morphine and transdermal fentanyl being the opioids most frequently administered. The mean admission time in hospice was 18.4 days. Eighty-six percent died in hospice. Palliative sedation was performed in 25 % of patients who died in hospice. The short survival and the number of patients dying in hospice were the principal finding, as it appears that hospice admission is only one way for end of life treatments. Patients receive specialized palliative care only for 2-3 weeks before death, implying an inacceptable timing for patients with several problems presumed to be present early during the course of disease. Data from hospice activities in Italy strongly suggest to spread palliative care in other settings, other than home care and hospice, to intercept oncologic patients in their disease trajectory early.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052914     DOI: 10.1007/s00520-012-1608-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  16 in total

Review 1.  Palliative sedation in patients with advanced cancer followed at home: a systematic review.

Authors:  Sebastiano Mercadante; Giampiero Porzio; Alessandro Valle; Flavio Fusco; Federica Aielli; Veruska Costanzo
Journal:  J Pain Symptom Manage       Date:  2011-01-12       Impact factor: 3.612

2.  The use of opioids in the last week of life in an acute palliative care unit.

Authors:  Sebastiano Mercadante; Patrizia Ferrera; Alessandra Casuccio
Journal:  Am J Hosp Palliat Care       Date:  2010-05-03       Impact factor: 2.500

3.  Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohort study. Italian Cooperative Research Group on Palliative Medicine.

Authors:  M Costantini; F Toscani; M Gallucci; C Brunelli; G Miccinesi; M Tamburini; E Paci; P Di Giulio; C Peruselli; I Higginson; J Addington-Hall
Journal:  J Pain Symptom Manage       Date:  1999-10       Impact factor: 3.612

4.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

5.  The last three months of life of Italian cancer patients. Methods, sample characteristics and response rate of the Italian Survey of the Dying of Cancer (ISDOC).

Authors:  Massimo Costantini; Monica Beccaro; Franco Merlo
Journal:  Palliat Med       Date:  2005-12       Impact factor: 4.762

6.  Home palliative care for terminal cancer patients: a survey on the final week of life.

Authors:  C Peruselli; P Di Giulio; F Toscani; M Gallucci; C Brunelli; M Costantini; M Tamburini; E Paci; G Miccinesi; J M Addington-Hall; I J Higginson
Journal:  Palliat Med       Date:  1999-05       Impact factor: 4.762

7.  An Italian survey on the attitudes in treating breakthrough cancer pain in hospice.

Authors:  Sebastiano Mercadante; Patrizia Villari; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2010-07-04       Impact factor: 3.603

8.  Interval between palliative care referral and death among patients treated at a comprehensive cancer center.

Authors:  Wen-Wu Cheng; Jie Willey; J Lynn Palmer; Tao Zhang; Eduardo Bruera
Journal:  J Palliat Med       Date:  2005-10       Impact factor: 2.947

Review 9.  Palliative care in Italy: problem areas emerging from the literature.

Authors:  S Mercadante; V Vitrano
Journal:  Minerva Anestesiol       Date:  2010-07-08       Impact factor: 3.051

10.  Clinical and financial analysis of an acute palliative care unit in an oncological department.

Authors:  S Mercadante; G Intravaia; P Villari; P Ferrera; F David; A Casuccio; S Mangione
Journal:  Palliat Med       Date:  2008-09       Impact factor: 4.762

View more
  12 in total

1.  The poor use of methadone in Italian hospices.

Authors:  Sebastiano Mercadante; Alessandro Valle; Cristina Agnelotti; Amanda Caruselli
Journal:  Support Care Cancer       Date:  2013-03-16       Impact factor: 3.603

2.  Age differences in the last week of life in advanced cancer patients followed at home.

Authors:  Sebastiano Mercadante; Federica Aielli; Francesco Masedu; Marco Valenti; Lucilla Verna; Giampiero Porzio
Journal:  Support Care Cancer       Date:  2015-10-16       Impact factor: 3.603

3.  Characteristics and care pathways of advanced cancer patients in a palliative-supportive care unit and an oncological ward.

Authors:  Sebastiano Mercadante; Paolo Marchetti; Claudio Adile; Amanda Caruselli; Patrizia Ferrera; Andrea Costanzi; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2018-01-08       Impact factor: 3.603

4.  Characteristics of patients with an unplanned admission to an acute palliative care unit.

Authors:  Sebastiano Mercadante; Claudio Adile; Patrizia Ferrera; Alessandra Casuccio
Journal:  Intern Emerg Med       Date:  2017-02-03       Impact factor: 3.397

5.  Symptom Expression in Patients with Advanced Cancer Admitted to an Acute Supportive/Palliative Care Unit With and Without Delirium.

Authors:  Sebastiano Mercadante; Claudio Adile; Patrizia Ferrera; Andrea Cortegiani; Alessandra Casuccio
Journal:  Oncologist       Date:  2018-10-24

6.  Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit.

Authors:  Sebastiano Mercadante; Giovanna Prestia; Maurizio Ranieri; Antonello Giarratano; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2013-02-12       Impact factor: 3.603

7.  Prevalence of delirium in advanced cancer patients in home care and hospice and outcomes after 1 week of palliative care.

Authors:  Sebastiano Mercadante; Francesco Masedu; Isabella Balzani; Daniela De Giovanni; Luigi Montanari; Cristina Pittureri; Raffaella Bertè; Domenico Russo; Laura Ursini; Franco Marinangeli; Federica Aielli
Journal:  Support Care Cancer       Date:  2017-10-05       Impact factor: 3.603

8.  Symptom expression in advanced cancer patients admitted to hospice or home care with and without delirium.

Authors:  Sebastiano Mercadante; Francesco Masedu; Marco Maltoni; Daniela De Giovanni; Luigi Montanari; Cristina Pittureri; Raffaella Bertè; Domenico Russo; Laura Ursini; Franco Marinangeli; Federica Aielli
Journal:  Intern Emerg Med       Date:  2018-10-17       Impact factor: 3.397

9.  The Palliative-Supportive Care Unit in a Comprehensive Cancer Center as Crossroad for Patients' Oncological Pathway.

Authors:  Sebastiano Mercadante; Claudio Adile; Amanda Caruselli; Patrizia Ferrera; Andrea Costanzi; Paolo Marchetti; Alessandra Casuccio
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

10.  What determines duration of palliative care before death for patients with advanced disease? A retrospective cohort study of community and hospital palliative care provision in a large UK city.

Authors:  Michael I Bennett; Lucy Ziegler; Matthew Allsop; Sunitha Daniel; Adam Hurlow
Journal:  BMJ Open       Date:  2016-12-09       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.